MIM
BDSX icon

Monashee Investment Management’s Biodesix BDSX Stock Holding History

Monashee Investment Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-112,344
Closed -$764K – 46
2025
Q4 		$764K Buy
112,344
+12,348
+12% +$90.9K 0.43% 37
2025
Q3 		$755K Sell
99,996
-4
-0% -$31 0.38% 54
2025
Q2 		$564K Sell
100,000
-102,500
-51% -$828K 0.2% 53
2025
Q1 		$2.53M Buy
202,500
+27,456
+16% +$527K 0.3% 38
2024
Q4 		$5.36M Hold
175,044
– – 0.73% 15
2024
Q3 		$6.23M Buy
175,044
+12,000
+7% +$413K 0.67% 20
2024
Q2 		$4.99M Buy
+163,044
New +$4.66M 0.65% 20
2021
Q1 		– Sell
-5,299
Closed -$2.14M – 382
2020
Q4 		$2.14M Buy
+5,299
New +$1.65M 0.28% 93

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Monashee Investment Management's BDSX Position: Q1 2026 in Review

Monashee Investment Management sold out of Biodesix (BDSX) in Q1 2026, closing a stake of 112,344 shares — an estimated $764K sold.

Monashee Investment Management first reported a position in BDSX in Q4 2020 and held it in 8 quarters. The position peaked at $6.23M in Q3 2024. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Monashee Investment Management reported no remaining Biodesix position as of Q1 2026 after selling out during the quarter.
  • Monashee Investment Management sold 112,344 Biodesix shares in Q1 2026, an estimated $764K.
  • Monashee Investment Management first reported a position in Biodesix in Q4 2020 and held it in 8 quarters.
  • Monashee Investment Management's Biodesix position peaked at $6.23M in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Monashee Investment Management's 13F filing for Q1 2026, filed 13 May 2026.